We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiologic Study Evaluating Infections in Elderly Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00900952
Recruitment Status : Completed
First Posted : May 13, 2009
Last Update Posted : October 9, 2009
Sponsor:
Information provided by:

May 7, 2009
May 13, 2009
October 9, 2009
March 2009
June 2009   (Final data collection date for primary outcome measure)
Prevalence of each kind of infection will be measured from a descriptive point of view, using relative and absolute frequencies. [ Time Frame: 5 months ]
Same as current
Complete list of historical versions of study NCT00900952 on ClinicalTrials.gov Archive Site
  • Study the etiology and resistance pattern for the main causal agents. [ Time Frame: 5 months ]
  • Describe the demographic features, co-morbidities, concomitant treatment and outcome of patients. [ Time Frame: 5 months ]
Same as current
Not Provided
Not Provided
 
Epidemiologic Study Evaluating Infections in Elderly Patients
Epidemiologic Study of Infections in Elderly Patients
The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Infected elderly patients treated at Internal Medicine wards in Spanish hospitals
Infection
Other: Clinical record review
1
Infected elderly patients
Intervention: Other: Clinical record review
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
240
June 2009
June 2009   (Final data collection date for primary outcome measure)

Inclusion criteria:

  • Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment
  • Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria:

  • COPD exacerbation
  • Urinary tract infections
  • Hospital acquired infections
  • Other infections not in inclusion criteria
Sexes Eligible for Study: All
65 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT00900952
3074X1-4489
No
Not Provided
Not Provided
Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
October 2009